Back to Journals » Drug Design, Development and Therapy » Volume 13

Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report

Total article views   HTML views PDF downloads Totals
7,234 Dovepress* 5,925+ 1,482 7,407
PubMed Central* 1,309 384 1,693
Totals 7,234 1,866 9,100
*Since 11 January 2019
Total mentioned Facebook Delicious Reddit Twitter Others
12 0 0 0 4 8

View citations on PubMed Central and Google Scholar